Corient Private Wealth LP Acquires New Shares in The Clorox Company $CLX

Corient Private Wealth LP bought a new stake in shares of The Clorox Company (NYSE:CLX – Free Report) during the 2nd quarter, HoldingsChannel reports. The firm bought 69,377 shares of the company’s stock, valued at approximately $6,621,000.

A number of other institutional investors and hedge funds have also modified their holdings of CLX. Caitlin John LLC raised its stake in shares of Clorox by 1,807.1% in the fourth quarter. Caitlin John LLC now owns 267 shares of the company’s stock worth $27,000 after purchasing an additional 253 shares during the last quarter. Ancora Advisors LLC purchased a new stake in shares of Clorox during the second quarter valued at $28,000. Avalon Trust Co bought a new stake in Clorox in the 2nd quarter worth about $29,000. Darwin Wealth Management LLC bought a new stake in Clorox in the 2nd quarter worth about $29,000. Finally, Root Financial Partners LLC raised its position in Clorox by 83.8% in the 1st quarter. Root Financial Partners LLC now owns 318 shares of the company’s stock worth $33,000 after buying an additional 145 shares during the last quarter. Institutional investors own 78.53% of the company’s stock.

Get Clorox alerts:

Clorox Stock Up 0.0%

CLX stock opened at $102.57 on Monday. The company has a market cap of $12.40 billion, a price-to-earnings ratio of 21.28, a P/E/G ratio of 3.21 and a beta of 0.54. The company has a debt-to-equity ratio of 15.80, a quick ratio of 0.38 and a current ratio of 0.66. The business’s 50-day moving average is $99.83 and its two-hundred day moving average is $102.60. The Clorox Company has a fifty-two week low of $84.70 and a fifty-two week high of $128.90.

Clorox (NYSE:CLX – Get Free Report) last released its quarterly earnings results on Monday, August 3rd. The company reported $1.66 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.64 by $0.02. Clorox had a return on equity of 522.23% and a net margin of 8.74%.The business had revenue of $1.95 billion during the quarter, compared to the consensus estimate of $1.91 billion. During the same period in the previous year, the company posted $2.87 EPS. The business’s quarterly revenue was down 2.0% compared to the same quarter last year. Clorox has set its FY 2027 guidance at 5.700-6.000 EPS. As a group, analysts forecast that The Clorox Company will post 5.8 earnings per share for the current year.

Clorox Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, August 28th. Investors of record on Wednesday, August 12th were given a dividend of $1.25 per share. This represents a $5.00 annualized dividend and a yield of 4.9%. This is a positive change from Clorox’s previous quarterly dividend of $1.24. The ex-dividend date was Wednesday, August 12th. Clorox’s dividend payout ratio (DPR) is presently 103.73%.

Wall Street Analyst Weigh In

Several equities analysts have issued reports on the stock. BNP Paribas Exane lowered their target price on shares of Clorox from $97.00 to $95.00 and set a “neutral” rating on the stock in a research note on Monday, July 20th. UBS Group boosted their price objective on shares of Clorox from $100.00 to $105.00 and gave the company a “neutral” rating in a report on Tuesday, August 4th. Jefferies Financial Group downgraded shares of Clorox from a “buy” rating to a “hold” rating and lowered their price objective for the company from $125.00 to $98.00 in a research report on Tuesday, July 28th. Citigroup raised their target price on shares of Clorox from $97.00 to $100.00 and gave the stock a “neutral” rating in a report on Tuesday, August 4th. Finally, Barclays reaffirmed an “underweight” rating and issued a $84.00 target price on shares of Clorox in a research report on Tuesday, August 4th. Twelve research analysts have rated the stock with a Hold rating and five have assigned a Sell rating to the stock. According to MarketBeat, the stock has a consensus rating of “Reduce” and an average price target of $102.40.

Get Our Latest Stock Report on Clorox

Clorox Profile

(Free Report)

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.

See Also

• Five stocks we like better than Clorox
• Strike a Balance Between Growth and Stability With These 3 Names Ready to Rally
• Rubrik’s AI Security Bet Could Power the Next Leg Higher
• Apple’s Foldable iPhone Could Be a Catalyst, But Not a Cure-All
• Snowflake Is Up Nearly 50% in 2026—What Are Short Sellers Betting Against?

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.